USPTO 2015–2025 USPTO PatentsView US Corporation

Joslin Diabetes Center

USPTO PatentsView assignee record - 22 granted patents across 11 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Joslin ranks #13,513 of 49,997 tracked US assignees by granted-patent volume, with 22 patents across 11 technology areas.

#13,513
of 49,997 US assignees by volume
Top 45%
by Innovation Score (37.0/100)
8.6
avg claims per patent
+0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13513 · US Corporation #13,513 · 22 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-FLAT · BOOK-FULL

  • GRANTS-SMALL 22 grants
  • MID-PACK #13,513/49,997
  • PHOTO-FINISH Jewelex New York
  • CPC-FOCUS A61K · 11 areas
  • INNOV-THIN 37.0/100
  • CLAIMS-PAR 8.6 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-FLAT +0% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Jewelex New York, Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Joslin’s 37.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Joslin

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Joslin's Innovation Score is 37.0/100 (top 45% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Joslin?

Each dot is one of Joslin’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Joslin’s own 8.6 claims/patent is at or below the 15.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Joslin vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 21.921.92222.1 0510152025 Granted patents (volume) Avg claims / patent Jewelex New York, Ltd. - 22, 1.41Jewelex New YorkJichi Medical University - 22, 11.68Jichi Medical Uni…Johnson Controls Light Commercial IP GmbH - 22, 17.82Johnson Controls…Johnson Matthey Catalysts (Germany) GmbH - 22, 16.45Johnson Matthey C…KCC Corporation - 22, 9.68KCCKiefel GMBH - 22, 18.09KiefelKnorr-bremse Gesellschaft MIT BESCHRÄNKTER Haftung - 22, 15.5Knorr-bremse Gese…Kromek Limited - 22, 19.77KromekJoslin Diabetes Center - 22, 8.55Joslin Diabetes C…
Joslin vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Joslin's grants concentrate

Joslin Diabetes Center is a focused PatentsView assignee: 11 CPC subclasses with 81.8% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2016 (4 grants) versus a trough of 1 in 2015. By volume, Joslin sits between Jewelex New York, Ltd. and Kromek Limited.

Joslin's three-year grant acceleration

Joslin Diabetes Center shows 7 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Joslin's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Joslin holds 22 patents at rank #13,511, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Joslin

By rank, the assignees closest to #13,511 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Joslin's primary technology class.

Joslin's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 45% higher than 55% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 2015201620172018201920202021202220232024 4
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Joslin Diabetes Center patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 4.5%
2016 4 18.2%
2017 3 13.6%
2018 2 9.1%
2019 1 4.5%
2020 2 9.1%
2021 2 9.1%
2022 2 9.1%
2023 1 4.5%
2024 4 18.2%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Joslin Diabetes Center's patent record in context - here's where to go next.

  • Joslin Diabetes Center's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 81.8% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #13,513 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Joslin Diabetes Center against Jewelex New York, Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 37.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.